Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

Roehrborn Claus G.; Egan Kathryn B.; Miner Martin M.; Ni Xiao; Wong David G.; Rosen Raymond C.

首页> 外文期刊>BJU international >Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

【24h】

Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

机译：治疗12周后与他达拉非联用的良性前列腺增生症（LUTS / BPH）引起的勃起功能障碍和下尿路症状

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：目的

著录项

来源
《BJU international》 |2016年第1期|共8页
作者
Roehrborn Claus G.; Egan Kathryn B.; Miner Martin M.; Ni Xiao; Wong David G.; Rosen Raymond C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
LUTS; BPH; erectile dysfunction; tadalafil;

机译：LUTS;BPH;勃起功能障碍;他达拉非;

相似文献

外文文献
中文文献
专利

1. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment [J] . Roehrborn Claus G., Egan Kathryn B., Miner Martin M., BJU international . 2016,第1期

机译：治疗12周后与他达拉非联用的良性前列腺增生症（LUTS / BPH）引起的勃起功能障碍和下尿路症状
2. Tadalafil Once Daily Improves Ejaculatory Function, Erectile Function, and Sexual Satisfaction in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and Erectile Dysfunction: Results from a Randomized, Placebo- and Tamsulosin-Controlled, 12-Week Double-Blind Study [J] . GiulianoF., OelkeM., JungwirthA., The journal of sexual medicine . 2013,第3期

机译：他达拉非每天一次可改善男性下尿路症状提示良性前列腺增生和勃起功能障碍的男性的射精功能，勃起功能和性满意度：来自一项随机，安慰剂和坦索罗辛控制的12周双盲研究的结果
3. Reply from authors re: Steven A. Kaplan. Tadalafil for the Treatment of Benign Prostatic Hyperplasia: When the moment does not add Up. Eur Urol 2013;63:517-8: Tadalafil in the treatment of men with lower urinary tract symptoms and/or erectile dysfunction symptoms [J] . GiulianoF., ViktrupL. European urology . 2013,第3期

机译：作者的回复：史蒂文·卡普兰（Steven A. Kaplan）。他达拉非治疗良性前列腺增生：当此刻加起来时。 Eur Urol 2013; 63：517-8：他达拉非用于治疗下尿路症状和/或勃起功能障碍症状的男性
4. New Surgical Treatment Options in Patients with Benign Prostate Hyperplasia (BPH) [C] . Werner T.W. de Riese, Thomas Nelius, David R. Aronoff, Conference on lasers in surgery: Advanced characterization, therapeutics, and systems . 2003

机译：良性前列腺增生（BPH）患者的新手术治疗方案
5. Analysis of Single Nucleotide Polymorphisms (SNPs) and Dose-volume Parameters on Predicting for Rectal Toxicity, Erectile Dysfunction, and Urinary Morbidity Following Treatment for Prostate Cancer Using Radiotherapy. [D] . Taneja, Sameer. 2014

机译：分析单核苷酸多态性（SNP）和剂量参数对使用放射疗法治疗前列腺癌后的直肠毒性，勃起功能障碍和尿毒症的预测。
6. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil [O] . Hyun Jun Park, Ji Eon Joanne Won, Sebastian Sorsaburu, 2013

机译：继发于亚洲男性的良性前列腺增生（BPH）和具有勃起功能障碍的LUTS / BPH继发尿路症状（LUTS）：以他达拉非为中心的系统评价
7. PIH99 Patient Characteristics and Medication Treatment Patterns Among Men With Erectile Dysfunction (Ed), Lower Urinary Tract Symptoms Secondary To Benign Prostatic Hyperplasia (Bph-Luts), Or Co-Occurring Ed and Bph-Luts In the Uk Primary Care Setting [O] . Ilo D., Raluy-Callado M., Graham-Clarke P., 2014

机译：在英国基层医疗机构中患有勃起功能障碍（Ed），继发于前列腺增生（Bph-Luts）的继发性下尿路症状或合并发生Ed和Bph-Lut的男性中的PIH99患者特征和药物治疗模式

Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

摘要

著录项

相似文献

相关主题

期刊订阅